시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 Fill-Finish 제조 시장(-2030년) : 제품(소모품(PFS, 플런저 스톱퍼), 바이알, 바이아르스툽파, 카트리지, 세포치료 백), 기구), Fill-Finish 서비스, 최종사용자별
Fill Finish Manufacturing Market by Product ((Consumables (PFS, Plunger Stopper), Vial, Vial Stoppers, Cartridge, Cell Therapy Bags), Instruments ), Fill Finish Service, End User - Global Forecast to 2030
상품코드 : 1804838
리서치사 : MarketsandMarkets
발행일 : 2025년 08월
페이지 정보 : 영문 466 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,950 ￦ 7,184,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,650 ￦ 9,651,000
PDF (5-user License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,150 ￦ 11,828,000
PDF (Corporate License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 ￦ 14,514,000
PDF (Global License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

세계의 Fill-Finish 시장 규모는 2025년 183억 6,000만 달러에서 예측 기간 중 CAGR 8.9%로 성장을 지속하여, 2030년에는 281억 4,000만 달러에 이를 것으로 예측됩니다.

이 시장의 확대는 주로 Annex-1 준수 요건에 의해 주도되고 있으며, 이로 인해 장비 업그레이드, 자동화 및 소량 생산 솔루션에 대한 수요가 증가하고 있습니다.

조사 범위
조사 대상 연도 2024-2030년
기준 연도 2024년
예측 기간 2025-2030년
단위 금액(달러)
부문 제품 유형, 최종사용자, 지역
대상 지역 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

그러나 아이솔레이터와 로봇에 의한 무균라인 도입에 많은 설비투자가 필요하다는 점, CDMO의 인력 부족으로 인해 무균 작업에 숙련된 인력이 부족하다는 점이 시장 성장을 저해할 것으로 예측됩니다.

Fill Finish Manufacturing Market-IMG1

"제품 유형별로는 소모품 부문이 가장 큰 점유율을 차지했습니다."

소모품은 의약품의 충전 및 포장 공정에서 무균성, 안전성, 효율성을 보장하는 데 필수적인 역할을 하기 때문에 시장에서 가장 큰 점유율을 차지하고 있습니다. 여기에는 바이알, 주사기, 카트리지, 마개, 마개, 씰, 튜브, 필터, 커넥터와 같은 일회용 시스템이 포함됩니다. 프리필드시린지 및 일회용 기술의 채택이 증가함에 따라 고품질 소모품에 대한 수요가 급증하고 있으며, 특히 엄격한 무균 조건이 요구되는 바이오 의약품 및 백신에 대한 수요가 급증하고 있습니다.

또한, 사전 세척 및 멸균된 용기와 마개는 네스트 또는 트레이 형태로 제공되는 즉시 사용(RTU) 구성품으로 전환되어 오염 위험을 줄이고 작업 효율을 향상시켜 소모품의 우위를 더욱 강화하고 있습니다. 또한, 제약사들은 세계 공급 수요에 대응하기 위해 유연성과 속도를 중시하고 있으며, 다운타임과 교차 오염을 최소화할 수 있는 일회용 소모품을 선호하고 있습니다. CDMO와 바이오 제약사들도 필피니쉬 공정을 외주화하는 경향이 강화되고 있어, 표준화된 규제 준수 소모품에 대한 수요가 더욱 증가하고 있습니다.

단일클론항체, 세포-유전자치료제, mRNA 제품 등 주사제 개발 파이프라인이 확대되고 있는 점도 고성능 소모품 수요를 더욱 촉진하고 있습니다. 그 결과, 소모품은 필피니쉬 워크플로우에 필수적일 뿐만 아니라 진화하는 제약 제조 환경에서 혁신과 가치 창출을 위한 중요한 기회를 제공합니다.

세계의 필피니쉬(Fill Finish) 제조 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 기술 및 특허 동향, 법 및 규제 환경, 사례 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

제6장 Fill-Finish 시장 : 제품별

제7장 Fill-Finish 시장 : 최종사용자별

제8장 Fill-Finish 시장 : 지역별

제9장 경쟁 구도

제10장 기업 개요

제11장 부록

LSH
영문 목차

영문목차

The global fill finish manufacturing market is projected to reach USD 28.14 billion by 2030 from an estimated USD 18.36 billion in 2025, at a CAGR of 8.9% from 2025 to 2030. The expansion of the fill finish manufacturing market has been predominantly fueled by Annex-1 compliance requirements, driving equipment upgradation and increasing demand for automated & small-batch solutions.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsBy Product type, End users, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

However, the need for high capex for adoption of isolators and robotic aseptic lines, as well as skilled labor shortage in sterile operations due to high CDMO staffing, is expected to restrain market growth.

Fill Finish Manufacturing Market - IMG1

"The consumables segment held the highest share in the fill finish manufacturing market by product type."

The fill finish manufacturing market is segmented by product type into consumables and instruments. Consumables held the largest share in the fill finish manufacturing market due to their essential role in ensuring sterility, safety, and efficiency throughout the drug filling and packaging process. These include vials, syringes, cartridges, stoppers, seals, and disposable systems such as tubing, filters, and connectors. With the increasing adoption of prefilled syringes and single-use technologies, the demand for high-quality consumables has surged, particularly for biologics and vaccines that require stringent aseptic conditions. The shift toward ready-to-use (RTU) components, such as pre-washed and sterilized containers and closures in nested & tray formats, further drives the dominance of consumables, as they help reduce contamination risks and streamline operations. Moreover, pharmaceutical manufacturers are prioritizing flexibility and speed to meet global supply demands, making single-use consumables a preferred choice for reducing downtime and cross-contamination. CDMOs and biopharma companies are also increasingly outsourcing fill-finish operations, amplifying the need for standardized and regulatory-compliant consumable products. The growing pipeline of injectable therapies, including monoclonal antibodies, cell and gene therapies, and mRNA-based products, will continue to elevate the demand for high-performance consumables. As a result, consumables are not only indispensable to fill finish workflows but also represent a critical opportunity for innovation and value creation in the evolving pharmaceutical manufacturing landscape.

"CMO segment reported for the highest share of the end user segment in 2024."

The Contract Manufacturing Organizations (CMOs) segment accounted for the largest share of the global fill finish manufacturing market. Based on end users, the market is categorized into CMOs, pharmaceutical and biopharmaceutical companies, and other end users such as Contract Research Organizations (CROs) and academic research institutions. CMOs have gained a strong foothold due to the growing trend of outsourcing fill finish operations, driven by the need for cost-effective and efficient manufacturing solutions. As drug development becomes more complex and time-sensitive, pharmaceutical and biopharmaceutical companies increasingly rely on CMOs to access specialized expertise, reduce capital investment, and accelerate time-to-market while simultaneously reducing costs & freeing up in-house capacity for non-core drugs. CMOs offer advanced capabilities, including aseptic processing, flexibility in batch sizes, and compliance with evolving regulatory standards, making them attractive partners in the highly competitive pharmaceutical landscape. The demand for high-quality, scalable, and reliable manufacturing services continues to rise, particularly for biologics and injectable drugs. As a result, the dominance of CMOs in the fill-finish space is expected to strengthen further, supported by ongoing investment in infrastructure, technology, and global supply chain integration.

"Europe accounted for the highest market share in the global fill finish manufacturing market from 2025 to 2030."

Europe holds the highest market share in the global fill-finish manufacturing market, driven by its strong pharmaceutical and biotechnology infrastructure, well-established regulatory framework, and presence of leading industry players. Countries such as Germany, Switzerland, France, and the UK are home to several top pharmaceutical companies and contract manufacturing organizations (CMOs) that offer advanced fill finish capabilities. The region benefits from significant investments in research and development, high adoption of innovative drug delivery systems, and a growing demand for biologics and personalized medicines. Additionally, Europe's strict regulatory standards promote the use of high-quality, sterile, and compliant fill-finish processes, further boosting the demand for specialized manufacturing solutions. The increasing focus on vaccine production and pandemic preparedness has also enhanced fill finish capacity across the region. Furthermore, government support for pharmaceutical innovation and public-private partnerships continues to strengthen the region's manufacturing capabilities. As a result, Europe remains a dominant force in the fill finish manufacturing landscape, offering growth opportunities for companies with advanced technologies, scalable solutions, and strong quality assurance systems.

The primary interviews conducted for this report can be categorized as follows:

List of Key Companies Profiled in the Report:

Key players in the fill finish manufacturing market include Syntegon Technology GmbH (Germany), I.M.A. S.P.A. (Italy), BD & Co.(US), West Pharmaceutical Services Inc. (US), Gerresheimer AG (Germany), AptarGroup Inc. (US), Datwyler Holding Inc. (Belgium), Danaher (US), Stevanato Group S.p.A. (Italy), OPTIMA (Germany), Bausch+Strobel (Germany), Groninger & Co. GmbH (Germany), SGD PHARMA (France), SCHOTT (Germany), Nipro Corporation (Japan), Bausch Advanced Technology Group (US), and Maquinaria Industrial Dara SI (Spain).

Research Coverage:

This research report categorizes the fill finish manufacturing market, By Product (Consumables (Pre-fillable Syringes (By components (Pre-fillable Syringe Systems & Components, Plunger Stopper)) By Material (Glass Pre-filled Syringes, Polymer Pre-filled Syringes)), Vial (By Material (Glass Vials, Polymer Vials), By Format (Bulk Vials, RTU Vials)), Vial stoppers (By Type (RTS/RFS Vial Stoppers, RTU Vial Stoppers)), Cartridge, Cell Therapy Fill Finish Bags and other consumables), Instruments (By System Type (Integrated Systems, Standalone Systems), By Machine Type (Automated Machines, Semi-Automated & Manual Machines), End User (Contract Manufacturing Organization (CMOs), Pharmaceutical & Biopharmaceutical Companies and Other end users) and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the fill finish manufacturing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the fill finish manufacturing market.

Key Benefits of Buying the Report:

The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall fill finish manufacturing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 FILL FINISH MANUFACTURING MARKET, BY PRODUCT

7 FILL FINISH MANUFACTURING MARKET, BY END USER

8 FILL FINISH MANUFACTURING MARKET, BY REGION

9 COMPETITIVE LANDSCAPE

10 COMPANY PROFILES

11 APPENDIX

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기